Oncology News

High levels of coffee consumption were found to be associated with a decreased risk for incident hepatocellular carcinoma and chronic liver disease mortality in multiethnic US populations, according to new research data.

The presence of clinically significant portal hypertension in patients with cirrhosis increased mortality and decompensation after surgery for hepatocellular carcinoma, according to recent study data.

A novel clinicopathologic prognostic nomogram developed by researchers at the University of California, Los Angeles, accurately predicted liver transplant recipients’ chance of hepatocellular carcinoma recurrence post-transplant, according to new study data.

Children in China who received the hepatitis B virus infection vaccination at birth had a reduced risk for primary liver cancer and other liver diseases when reaching young adulthood, according to new study data.

Among a cohort of Korean patients with hepatocellular carcinoma, high aldo-keto reductase 1B10 protein expression predicted longer recurrence-free and disease-specific survival rates vs. patients with low protein expression.

Data from the Global Burden of Disease Study 2013 suggest that global life expectancy has increased by 5.8 years among men and 6.6 years among women from 1990 to 2013.

Normalization of inflammation-based index score after transarterial chemoembolization therapy among patients with hepatocellular carcinoma predicted a greater overall survival, according to study data.

Liver transplant recipients in the long waiting time region who underwent transplantation due to hepatocellular carcinoma had a greater survival rate after transplant compared with patients on the short waiting time region list, according to study data.

Patients with hepatitis B virus infection treated with long-term nucleoside analogue therapy had a decreased risk for developing hepatitis B virus infection-related hepatocellular carcinoma, according to study data.

UT Southwestern Medical Center was awarded $1.35 million by the Cancer Prevention and Research Institute of Texas for research in the treatment of hepatocellular carcinoma and liver cirrhosis, according to a release from the medical center.